Screener
Janux Therapeutics JANX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's operating margin?
- Janux Therapeutics (JANX) reported operating margin of -598.1% in Q2 2026.
- How has Janux Therapeutics's operating margin changed year-over-year?
- Janux Therapeutics's operating margin increased by 98.2% year-over-year, from -33,002.1% to -598.1%.
- What is the long-term trend for Janux Therapeutics's operating margin?
- Over 4 years (2021 to 2025), Janux Therapeutics's operating margin has grown at a 14.9% compound annual growth rate (CAGR), from -905.4% to -1,576.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Janux Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude